IL140550A - Methods for early diagnosis of carcinomas - Google Patents
Methods for early diagnosis of carcinomasInfo
- Publication number
- IL140550A IL140550A IL14055099A IL14055099A IL140550A IL 140550 A IL140550 A IL 140550A IL 14055099 A IL14055099 A IL 14055099A IL 14055099 A IL14055099 A IL 14055099A IL 140550 A IL140550 A IL 140550A
- Authority
- IL
- Israel
- Prior art keywords
- carcinomas
- early diagnosis
- methods
- overexpression
- cell cycle
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19829473A DE19829473C2 (de) | 1998-07-01 | 1998-07-01 | Verfahren zur frühen Diagnose von Carcinomen |
| PCT/DE1999/002094 WO2000001845A2 (de) | 1998-07-01 | 1999-07-01 | Verfahren zur frühen diagnose von carcinomen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL140550A0 IL140550A0 (en) | 2002-02-10 |
| IL140550A true IL140550A (en) | 2005-08-31 |
Family
ID=7872684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14055099A IL140550A (en) | 1998-07-01 | 1999-07-01 | Methods for early diagnosis of carcinomas |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6709832B1 (zh) |
| EP (1) | EP1092155B1 (zh) |
| JP (1) | JP3404020B2 (zh) |
| KR (1) | KR100646193B1 (zh) |
| CN (1) | CN1209627C (zh) |
| AT (1) | ATE230487T1 (zh) |
| AU (1) | AU749769B2 (zh) |
| BR (1) | BRPI9912227B8 (zh) |
| CA (1) | CA2336153C (zh) |
| CZ (1) | CZ292076B6 (zh) |
| DE (2) | DE19829473C2 (zh) |
| DK (1) | DK1092155T3 (zh) |
| ES (1) | ES2190820T3 (zh) |
| HK (1) | HK1038609A1 (zh) |
| HU (1) | HUP0102744A2 (zh) |
| IL (1) | IL140550A (zh) |
| MX (1) | MXPA00012852A (zh) |
| NO (1) | NO328685B1 (zh) |
| PL (1) | PL198623B1 (zh) |
| RU (1) | RU2217761C2 (zh) |
| SK (1) | SK284056B6 (zh) |
| TR (1) | TR200003903T2 (zh) |
| WO (1) | WO2000001845A2 (zh) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7306926B2 (en) * | 1998-07-01 | 2007-12-11 | Mtm Laboratories Ag | Method for detecting carcinomas in a solubilized cervical body sample |
| AUPP991199A0 (en) * | 1999-04-21 | 1999-05-13 | University Of Sydney, The | Methods for diagnosing pre-cancerous and cancerous conditions |
| DE10006033B4 (de) * | 2000-02-10 | 2005-11-10 | Professor Dr. Magnus von Knebel Doeberitz Chirurgische Universitätsklinik Sektion für Molekulare Diagnostik und Therapie | Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen |
| US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US9249229B2 (en) | 2000-12-08 | 2016-02-02 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US7408041B2 (en) | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| AUPR201500A0 (en) * | 2000-12-11 | 2001-01-11 | Biosceptre Pty Ltd | Methods for identifying pre-neoplastic and neoplastic states in mammals |
| DE10063179A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
| ATE418565T1 (de) | 2001-01-17 | 2009-01-15 | Intreat Pty Ltd | Antikörper gegen nichtfunktionelle p 2 x 7 rezeptoren, diagnose und behandlung von krebs und anderen leiden |
| EP1369694A1 (en) | 2002-04-09 | 2003-12-10 | MTM Laboratories AG | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| DK1388734T3 (da) | 2002-08-01 | 2004-05-03 | Mtm Lab Ag | Metode til opløsningsbaseret diagnose |
| EP1507148B1 (en) * | 2003-08-25 | 2005-02-23 | MTM Laboratories AG | Method for detecting carcinomas in a solubilized cervical body sample |
| EP1422526A1 (en) | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Method for improved diagnosis of dysplasias |
| WO2004070062A2 (en) * | 2003-02-04 | 2004-08-19 | Wyeth | Compositions and methods for diagnosing and treating cancers |
| DE602004025676D1 (de) * | 2003-02-26 | 2010-04-08 | Sysmex Corp | Verfahren zur untersuchung einer zelle |
| US7157233B2 (en) * | 2004-03-24 | 2007-01-02 | Tripath Imaging, Inc. | Methods and compositions for the detection of cervical disease |
| DE602005024964D1 (de) * | 2004-05-31 | 2011-01-05 | Sysmex Corp | Verfahren zur beurteilung der malignität einer säuger-krebszelle |
| EP1628135A1 (en) * | 2004-08-20 | 2006-02-22 | MTM Laboratories AG | Method for detecting medically relevant conditions in a solubilized LBC sample |
| US7892750B1 (en) * | 2004-12-23 | 2011-02-22 | University Of Notre Dame Du Lac | Cathepsin E as a marker of colon cancer |
| JP4766969B2 (ja) | 2005-09-14 | 2011-09-07 | シスメックス株式会社 | 組織性質判定装置 |
| US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
| DK2463305T3 (en) | 2006-01-12 | 2016-08-29 | Alexion Pharma Inc | Antibodies to OX-2 / CD200 and uses thereof |
| US8067550B2 (en) * | 2006-10-10 | 2011-11-29 | Biosceptre International Limited | Hybridomas producing antibodies against non functional P2X7 receptor |
| US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
| US20100003704A1 (en) | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
| US8916342B2 (en) | 2006-11-13 | 2014-12-23 | Oncohealth Corp. | Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers |
| JP5111902B2 (ja) * | 2007-03-14 | 2013-01-09 | シスメックス株式会社 | 癌の診断支援装置 |
| EP2028600B1 (en) | 2007-08-24 | 2016-10-26 | Sysmex Corporation | Diagnosis support system for cancer, diagnosis support for information providing method for cancer, and computer program product |
| WO2009033234A1 (en) | 2007-09-14 | 2009-03-19 | Biosceptre International Limited | Purinergic (p2x) receptors in extra-cellular body fluid |
| EP2201026B1 (en) | 2007-09-14 | 2017-01-04 | Biosceptre (Aust) Pty Ltd | Novel p2x7 epitopes |
| NZ590146A (en) * | 2008-07-04 | 2012-09-28 | Biosceptre Int Ltd | Antibodies which bind an epitope comprising two different monomers of the P2X7 receptor |
| ES2704711T3 (es) | 2009-08-20 | 2019-03-19 | Biosceptre Aust Pty Ltd | Anticuerpos anti-receptor P2X7 y fragmentos de los mismos |
| CN102762595B (zh) | 2009-12-24 | 2016-03-02 | 生物权威国际有限公司 | 针对非功能性低聚p2x7受体的抗体 |
| EP2521914A4 (en) | 2010-01-08 | 2013-07-10 | Oncohealth Corp | CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER |
| US8900813B2 (en) | 2010-08-17 | 2014-12-02 | Medical Diagnostic Laboratories, Llc | CIP2A as a biomarker in detection of cervical cancer |
| EP2613808B1 (en) | 2010-09-10 | 2017-11-08 | Biosceptre (Aust) Pty Ltd | Companion animal cancer treatments with an anti p2x7 antibody |
| US9551700B2 (en) | 2010-12-20 | 2017-01-24 | Milagen, Inc. | Device and methods for the detection of cervical disease |
| BR112013033974A2 (pt) | 2011-07-01 | 2017-02-14 | Biosceptre Int Ltd | terapia de combinação |
| JP6301258B2 (ja) | 2011-11-03 | 2018-03-28 | トライパス イメージング インコーポレイテッド | 免疫染色試料を調製するための方法および構成物 |
| AU2012340441A1 (en) | 2011-11-15 | 2014-05-29 | University Of Miami | Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma |
| US11761963B2 (en) | 2017-09-27 | 2023-09-19 | Alexion Pharmaceuticals, Inc. | Biomarker signature for predicting tumor response to anti-CD200 therapy |
| WO2019234176A1 (en) | 2018-06-07 | 2019-12-12 | Universitaet Des Saarlandes | Novel biomarkers for carcinoma diagnosis |
| CN108893534A (zh) * | 2018-06-26 | 2018-11-27 | 华中科技大学鄂州工业技术研究院 | 泛癌症诊断标记物 |
| RU2707884C1 (ru) * | 2018-10-03 | 2019-12-02 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Способ ранней диагностики почечно-клеточной карциномы по наличию антител к зрительному аррестину |
| FR3088640A1 (fr) | 2018-10-14 | 2020-05-22 | Smart Diagnostix Pharma | Nouveau polypeptide se liant specifiquement a la proteine p16 |
| CN111257565A (zh) * | 2018-12-03 | 2020-06-09 | 上海细胞治疗集团有限公司 | 一种衰老细胞的检测试剂盒及其检测方法 |
| CN113295683A (zh) * | 2021-05-24 | 2021-08-24 | 烟台海关技术中心 | 过氧化苯甲酰检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
| US5268463A (en) * | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
| DE69333043T2 (de) | 1992-10-16 | 2004-05-06 | Cold Spring Harbor Laboratory | Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen |
| WO1994012881A2 (en) * | 1992-12-02 | 1994-06-09 | Hochstrasser Denis F | A METHOD FOR DETECTING GROWING CELLS USING TRANSLATIONALLY CONTROLLED TUMOR PROTEIN p21 |
| US5543291A (en) * | 1993-01-29 | 1996-08-06 | Dana Farber Cancer Institute | Method of detecting carcinoma |
| US6316208B1 (en) * | 1994-01-07 | 2001-11-13 | Memorial Sloan-Kettering Cancer Center | Methods for determining isolated p27 protein levels and uses thereof |
| CN1128049A (zh) * | 1994-03-18 | 1996-07-31 | 犹他大学研究基金会 | 多肿瘤抑制因子基因种系突变及检测该基因癌肿倾向性的方法 |
| US5763190A (en) * | 1994-09-21 | 1998-06-09 | The Trustees Of The University Of Pennsylvania | Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein |
| US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
| US5976799A (en) | 1996-03-21 | 1999-11-02 | The Board Of Trustees Of The University Of Arkansas | Early detection of ovarian carcinoma using P16 gene products |
| US5851797A (en) * | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
| US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
| AU1230600A (en) * | 1998-10-28 | 2000-05-15 | President And Fellows Of Harvard College | Regulation of th2 cell activity by modulation of nfatp and nfat4 activity |
-
1998
- 1998-07-01 DE DE19829473A patent/DE19829473C2/de not_active Expired - Lifetime
-
1999
- 1999-07-01 JP JP2000558235A patent/JP3404020B2/ja not_active Expired - Lifetime
- 1999-07-01 BR BRPI9912227-8B1 patent/BRPI9912227B8/pt active IP Right Grant
- 1999-07-01 WO PCT/DE1999/002094 patent/WO2000001845A2/de active IP Right Grant
- 1999-07-01 US US09/743,103 patent/US6709832B1/en not_active Expired - Lifetime
- 1999-07-01 MX MXPA00012852A patent/MXPA00012852A/es active IP Right Grant
- 1999-07-01 DE DE59903915T patent/DE59903915D1/de not_active Expired - Lifetime
- 1999-07-01 HU HU0102744A patent/HUP0102744A2/hu unknown
- 1999-07-01 SK SK2031-2000A patent/SK284056B6/sk not_active IP Right Cessation
- 1999-07-01 KR KR1020017000026A patent/KR100646193B1/ko not_active IP Right Cessation
- 1999-07-01 ES ES99945931T patent/ES2190820T3/es not_active Expired - Lifetime
- 1999-07-01 DK DK99945931T patent/DK1092155T3/da active
- 1999-07-01 CZ CZ20004922A patent/CZ292076B6/cs not_active IP Right Cessation
- 1999-07-01 AU AU58487/99A patent/AU749769B2/en not_active Expired
- 1999-07-01 IL IL14055099A patent/IL140550A/xx not_active IP Right Cessation
- 1999-07-01 CA CA002336153A patent/CA2336153C/en not_active Expired - Lifetime
- 1999-07-01 AT AT99945931T patent/ATE230487T1/de active
- 1999-07-01 CN CNB998079111A patent/CN1209627C/zh not_active Expired - Lifetime
- 1999-07-01 EP EP99945931A patent/EP1092155B1/de not_active Expired - Lifetime
- 1999-07-01 PL PL345407A patent/PL198623B1/pl unknown
- 1999-07-01 RU RU2001102598/15A patent/RU2217761C2/ru active
- 1999-07-01 TR TR2000/03903T patent/TR200003903T2/xx unknown
-
2000
- 2000-12-28 NO NO20006681A patent/NO328685B1/no not_active IP Right Cessation
-
2001
- 2001-10-18 HK HK01107321A patent/HK1038609A1/xx not_active IP Right Cessation
-
2003
- 2003-02-20 US US10/371,883 patent/US20030152993A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL140550A0 (en) | Methods for early diagnosis of carcinomas | |
| HK1092219A1 (en) | Method for detecting neoplastic disorders in a solubilized body sample | |
| WO2000005265A3 (en) | Anti-crr2 antibodies and methods of use therefor | |
| EP1687283A4 (en) | PROCESS AND COMPOSITION FOR DETERMINING FK 506 | |
| MY138674A (en) | Radiolabeling kit and binding assay | |
| WO1999042090A3 (en) | Treating cancer | |
| EP1102988B8 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
| EP1708745A4 (en) | ANTIBODIES FOR ONCOGEN STRAINS OF HPV AND METHODS OF USE | |
| WO2000035950A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
| SE9604815D0 (sv) | A metod of diagnosis | |
| FR2816410B1 (fr) | Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire | |
| HK1044190A1 (en) | A method for identifying pre-neoplastic and/or neoplastic states in mammals | |
| AU7571998A (en) | Rapid evaluation of the ratio of biological molecules | |
| CA2366514A1 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
| GB9609653D0 (en) | Method of assay | |
| WO2001007471A3 (en) | Cell cycle and proliferation proteins | |
| AU4865997A (en) | Monoclonal antibodies against a human act and serine protease complex | |
| AU4908799A (en) | Determination of the hydrophobic pulmonary surfactant protein sp-c | |
| AU2002233278A1 (en) | Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit | |
| AU9437598A (en) | Method and kit for identifying interactions between proteins or peptides | |
| NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
| WO2001006226A3 (de) | Verfahren zur bestimmung der proliferationsaktivität von zellen | |
| AU4459197A (en) | Diagnosis aid and process for detecting pregnancy in ruminants | |
| UA34166A (uk) | Спосіб кількісного визначення піпемідієвої кислоти | |
| WO1998037092A3 (en) | Use of a novel disintegrin metalloprotease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |